IPEM Radiotherapy Biennial Meeting 2025
Emma Hall, The Institute of Cancer Research

Emma Hall, The Institute of Cancer Research

Emma Hall, Professor of Oncology Trials, is the Director of the Cancer Research UK-funded Clinical Trials and Statistics Unit at The Institute of Cancer Research (ICR-CTSU), London, UK. She is a chartered statistician with over 25 years’ experience in the design, methodology and analysis of oncology clinical trials.  She leads the ICR-CTSU’s portfolio of research in genitourinary and head and neck cancers with focus on the design and analysis of radiotherapy clinical trials.

She is a previous co-chair of the National Clinical Research Institute (NCRI)’s Clinical and Translational Radiotherapy Research Group (CTRad) workstream on Phase 3 Trials and Methodology and led the Cancer Research UK funded Advanced Radiotherapy Network’s methodology workstream. She sits on CTRad’s Proton Beam Clinical Trial Strategy Group and the National Institute for Health and Care Research funded National Radiotherapy Trials Quality Assurance Management Group.  She is an honorary member of the Royal College of Radiologists and an affiliate member of the European Society for Radiation and Oncology (ESTRO).

Professor Hall has served on funding committees for Cancer Research UK, Marie Curie Research and Yorkshire Cancer Research. She sits on the independent data monitoring and trial steering committees for a number of international and national clinical trials.

Dr Alan McWilliam, The Christie NHS Foundation Trust

Dr Alan McWilliam, The Christie NHS Foundation Trust

Dr Alan McWilliam is a Reader in Translational Radiotherapy Physics at The University of Manchester and honorary principal scientist at The Christie NHS Foundation Trust.  His primary research themes are 1) analysis of radiotherapy outcomes, primarily using voxel-based analysis techniques to best understand how the full, 3-dimensional, dose distribution affects patients’ response to radiation; and 2) the development of quantitative imaging biomarkers to inform patient risk stratification. 

Stuart Green, University Hospitals Birmingham NHS Foundation Trust

Stuart Green, University Hospitals Birmingham NHS Foundation Trust

Stuart has spent his career in the field of medical physics and now leads the medical physics team of ~ 200 staff at University Hospital Birmingham (UHB) NHS Trust. He is also Honorary Professor of Physics in the School of Physics and Astronomy, University of Birmingham and is co-Director of the CRUK Birmingham Centre of Excellence for Radiation Research. He has published over 100 papers mainly in the areas of radiation metrology and advanced radiotherapy techniques.  He was President of the British Institute for Radiology from 2009-10 and is currently Chair of Trustees of the LH Gray Memorial Trust. He is active in a number of international organisations including International Society for Neutron Capture Therapy.